Imagine a pregnancy test strip that is as accurate as a high-end hospital lab machine. This project creates these smart paper tests to find multiple diseases at once, even in remote villages. It then links the results to a mobile phone app to help doctors treat patients faster without needing a big city hospital.
Current high-accuracy diagnostics are too expensive and centralized for rural Africa, while cheap rapid tests lack the necessary sensitivity to treat co-morbidities effectively.
A system of paper-based isothermal amplification sensors for multiplexed detection and a connected mHealth platform for diagnostic decision support.
If you are a diagnostic producer dealing with high costs of lab-based nucleic acid tests — this project developed paper-based isothermal amplification sensors that provide high accuracy at a low cost. This allows for the production of affordable, self-contained test cassettes.
If you are a digital health company dealing with fragmented patient data in rural areas — this project developed a mobile health platform integrated with diagnostic outcomes. This enables connected diagnostics and personalized medicine via existing mobile payment infrastructure.
If you are a veterinary firm dealing with zoonotic infections like Brucellosis or Q Fever — this project developed febrile chips for human-livestock transmission studies. This helps in managing infectious diseases in livestock to protect both animals and humans.
Based on available project data, the specific price is not listed, but the objective is to create 'low-cost' diagnostics using paper-based materials to replace expensive centralized lab tests.
Yes, the project includes a focus on 'pilot manufacturing' in Senegal, specifically for multiplexed sensors and reagent stabilization.
Based on available project data, the project includes a 'comprehensive dissemination, exploitation, and communication action plan' to foster adoption by businesses and health authorities.
The solution is designed to integrate into existing African digital health infrastructure and leverage widespread mobile payment systems.
The project period runs from 2022-10-01 to 2027-09-30, indicating a multi-year development and clinical trial phase.
The consortium is highly diversified with 16 partners across 8 countries, blending academic research (4 universities, 7 research centers) with industrial application (2 SMEs, 2 industry partners). While the industry ratio is relatively low at 12%, the inclusion of INNOTROPE SAS as a coordinator and the specific focus on pilot manufacturing in Senegal suggests a strong push toward commercial viability.
Contact INNOTROPE SAS in France for licensing and partnership opportunities.
Contact SciTransfer to explore licensing opportunities for these low-cost diagnostic sensors.
